PNC Financial Services Group
IMDX

PNC Financial Services Group’s Insight Molecular Diagnostics IMDX Stock Holding History

PNC Financial Services Group’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-500
Closed -$1.48K – 4874
2024
Q2 		$1.48K Hold
500
– – ﹤0.01% 4335
2024
Q1 		$1.47K Hold
500
– – ﹤0.01% 4277
2023
Q4 		$1.25K Hold
500
– – ﹤0.01% 4273
2023
Q3 		$1.56K Hold
500
– – ﹤0.01% 4295
2023
Q2 		$2.3K Hold
500
– – ﹤0.01% 4342
2023
Q1 		$3.54K Hold
500
– – ﹤0.01% 4152
2022
Q4 		$3.21K Hold
500
– – ﹤0.01% 4132
2022
Q3 		$7K Hold
500
– – ﹤0.01% 3882
2022
Q2 		$9K Hold
500
– – ﹤0.01% 3846
2022
Q1 		$15K Buy
+500
New +$16K ﹤0.01% 3705
2021
Q4 		– Sell
-15
Closed -$1K – 4567
2021
Q3 		$1K Buy
+15
New +$1.38K ﹤0.01% 4212
2020
Q3 		– Sell
-1
Closed – – 4005
2020
Q2 		$0 Hold
1
– – ﹤0.01% 4007
2020
Q1 		$0 Hold
1
– – ﹤0.01% 4009
2019
Q4 		$0 Hold
1
– – ﹤0.01% 4069
2019
Q3 		$0 Hold
1
– – ﹤0.01% 4077
2019
Q2 		$0 Hold
1
– – ﹤0.01% 4099
2019
Q1 		$0 Hold
1
– – ﹤0.01% 4103
2018
Q4 		$0 Hold
1
– – ﹤0.01% 4137
2018
Q3 		$0 Hold
1
– – ﹤0.01% 4204
2018
Q2 		$0 Hold
1
– – ﹤0.01% 4230
2018
Q1 		$0 Hold
1
– – ﹤0.01% 4249
2017
Q4 		$0 Hold
1
– – ﹤0.01% 4212
2017
Q3 		$0 Hold
1
– – ﹤0.01% 4205
2017
Q2 		$0 Sell
1
-200
-100% -$22.8K ﹤0.01% 4206
2017
Q1 		$24K Hold
201
– – ﹤0.01% 3224
2016
Q4 		$28K Hold
201
– – ﹤0.01% 3093
2016
Q3 		$20K Hold
201
– – ﹤0.01% 3222
2016
Q2 		$14K Hold
201
– – ﹤0.01% 3403
2016
Q1 		$18K Buy
+201
New +$17.8K ﹤0.01% 3331

Other funds holding IMDX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's IMDX Position: Q3 2024 in Review

PNC Financial Services Group sold out of Insight Molecular Diagnostics (IMDX) in Q3 2024, closing a stake of 500 shares — an estimated $1.48K sold.

PNC Financial Services Group first reported a position in IMDX in Q1 2016 and held it in 29 quarters. The position peaked at $28K in Q4 2016. 21 funds tracked by Wall St. Rank hold IMDX as of Q3 2024.

  • PNC Financial Services Group reported no remaining Insight Molecular Diagnostics position as of Q3 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 500 Insight Molecular Diagnostics shares in Q3 2024, an estimated $1.48K.
  • PNC Financial Services Group first reported a position in Insight Molecular Diagnostics in Q1 2016 and held it in 29 quarters.
  • PNC Financial Services Group's Insight Molecular Diagnostics position peaked at $28K in Q4 2016.
  • 21 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q3 2024.

Based on PNC Financial Services Group's 13F filing for Q3 2024, filed 8 Nov 2024.